VRNA
Verona Pharma
VRNA
VRNA
Delisted
VRNA was delisted on the 6th of October, 2025.
102 hedge funds and large institutions have $1.07B invested in Verona Pharma in 2023 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 36 increasing their positions, 33 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
102
Holders Change
-3
Holders Change %
-2.86%
% of All Funds
1.63%
Holding in Top 10
9
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-25%
% of All Funds
0.14%
New
10
Increased
36
Reduced
33
Closed
13
Calls
$1.12M
Puts
$3.1M
Net Calls
-$1.98M
Net Calls Change
+$4.13M
Top Buyers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$19.8M |
| 2 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$13.9M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$13.4M |
| 4 |
Millennium Management
New York
|
+$6.53M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$4.63M |
Top Sellers
| 1 |
ABG
Ally Bridge Group
New York
|
-$10.3M |
| 2 |
FFM
Fairmount Funds Management
West Conshohocken,
Pennsylvania
|
-$8.07M |
| 3 |
PA
Perceptive Advisors
New York
|
-$6.36M |
| 4 |
Two Sigma Investments
New York
|
-$5.44M |
| 5 |
Two Sigma Advisers
New York
|
-$3.92M |
